Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
FDA OKs implant for enlarged prostate symptoms
WASHINGTON • Federal health regulators have approved the first permanent implant to treat men's urinary problems caused by an enlarged prostate.
The Food and Drug Administration says it approved the Urolift system to relieve low or blocked urine flow in men age 50 or older. The implant works by holding back prostate tissue that presses against the urethra, causing difficulty urinating.
More than half of men in their sixties have some urinary problems due to enlarged prostate, including frequent urination, weak stream and leaking. Current treatment options include drug therapy and surgery to remove part of the prostate. The Urolift is implanted by a doctor using a handheld device that is inserted through the urethra.
Side effects reported in company trials include pain during urination, blood in urine and decreased urine flow.